Alpa Laboratories (NSE:ALPA) E10: ₹5.63 (As of Mar. 2026)


NSE:ALPA Alpa Laboratories Ltd NSE:ALPA
73 GF Score
Price ₹68.50
GF Value ₹91.65
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Alpa Laboratories E10?

Alpa Laboratories NSE:ALPA -0.35% 73 E10 is ₹5.63 as of Mar. 2026. GuruFocus rates NSE:ALPA with a GF Score™ of 73/100 and a GF Value™ of ₹91.65 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Alpa Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹0.240. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹5.63 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Alpa Laboratories's average E10 Growth Rate was 33.70% per year. During the past 3 years, the average E10 Growth Rate was 45.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Alpa Laboratories was 45.20% per year. The lowest was 45.20% per year. And the median was 45.20% per year.

As of today (2026-06-29), Alpa Laboratories's current stock price is ₹68.50. Alpa Laboratories's E10 for the quarter that ended in Mar. 2026 was ₹5.63. Alpa Laboratories's Shiller PE Ratio of today is 12.17.

During the past 13 years, the highest Shiller PE Ratio of Alpa Laboratories was 45.53. The lowest was 9.21. And the median was 31.85.


Alpa Laboratories  (NSE:ALPA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Alpa Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=68.50/5.63
=12.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Alpa Laboratories was 45.53. The lowest was 9.21. And the median was 31.85.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Alpa Laboratories E10 Related Terms


Alpa Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Alpa Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpa Laboratories E10 Chart

Alpa Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.83 2.67 4.17 5.63

Alpa Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.17 4.98 5.30 5.46 5.63

NSE:ALPA vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpa Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alpa Laboratories's Shiller PE Ratio falls into.


NSE:ALPA
73GF Score
Alpa Laboratories Ltd NSE:ALPA
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpa Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alpa Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.24/164.2724*164.2724
=0.240

Current CPI (Mar. 2026) = 164.2724.

Alpa Laboratories Quarterly Data

per share eps CPI Adj_EPS
201406 -1.040 94.103 -1.816
201409 -0.590 96.780 -1.001
201412 -0.730 96.780 -1.239
201503 1.700 97.163 2.874
201506 1.410 99.841 2.320
201509 2.790 101.753 4.504
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201809 0.090 115.142 0.128
201812 1.130 115.142 1.612
201903 -1.470 118.202 -2.043
201906 0.580 120.880 0.788
201909 0.184 123.175 0.245
201912 1.230 126.235 1.601
202003 0.111 124.705 0.146
202006 1.530 127.000 1.979
202009 0.190 130.118 0.240
202012 1.770 130.889 2.221
202103 -0.960 131.771 -1.197
202106 3.060 134.084 3.749
202109 2.720 135.847 3.289
202112 2.570 138.161 3.056
202203 -1.660 138.822 -1.964
202206 1.290 142.347 1.489
202209 0.100 144.661 0.114
202212 2.430 145.763 2.739
202303 2.080 146.865 2.327
202306 1.710 150.280 1.869
202309 2.750 151.492 2.982
202312 2.170 152.924 2.331
202403 1.663 153.035 1.785
202406 2.420 155.789 2.552
202409 3.660 157.882 3.808
202412 4.230 158.323 4.389
202503 -0.950 157.552 -0.991
202506 5.590 159.755 5.748
202509 0.050 162.289 0.051
202512 0.900 163.281 0.905
202603 0.240 164.272 0.240

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹5.63 mean?
Alpa Laboratories (NSE:ALPA) has a E10 of ₹5.63 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Alpa Laboratories and its competitors.
Is Alpa Laboratories' E10 too high?
Alpa Laboratories' current E10 is ₹5.63. Overall, Alpa Laboratories has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alpa Laboratories' E10 compare to ZTS and UTHR?
Alpa Laboratories' E10 of ₹5.63 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Alpa Laboratories and its competitors. Alpa Laboratories's current E10 is ₹5.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alpa Laboratories (NSE:ALPA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹91.65, compared to a current price of ₹68.50 — trading 25.3% below its estimated fair value. The current E10 is ₹5.63. Alpa Laboratories' overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Alpa Laboratories (NSE:ALPA), the current E10 is ₹5.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alpa Laboratories (NSE:ALPA) Overvalued in 2026?

Based on GuruFocus' analysis, Alpa Laboratories stock appears to be undervalued. The current stock price of ₹68.50 is trading 25.3% below its estimated GF Value™ of ₹91.65. GuruFocus considers Alpa Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:ALPA:

  • E10: ₹5.63
  • GF Value™: ₹91.65 vs. price of ₹68.50 (25.3% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the NSE:ALPA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alpa Laboratories Business Description

Other Exchanges 532878:India
Address 33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the drug and chemical business segment. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.
73GF Score

Get the complete analysis for NSE:ALPA

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹68.50
Price
₹91.65
GF Value